Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

A young man was unexpectedly diagnosed with basal cell carcinoma after a scalp examination and confocal microscopy.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

The treatment was ineffective in humans.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

A rare benign tumor was found in a man's scrotum, highlighting the need for accurate diagnosis.

Basal cell epithelioma likely starts from the hair follicle's outer root sheath.